Orthofix Medical, Inc. (OFIX)
9.70
+0.07
(+0.73%)
USD |
NASDAQ |
Aug 28, 16:00
9.70
0.00 (0.00%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 395.08M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -34.19% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 0.4689 |
| Price to Book Value | 0.9205 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.6102 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 85.69% |
Profile
| Orthofix Medical, Inc. develops and markets medical devices and biologic solutions for spine and orthopedic applications. The company operates through two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers two primary product categories: Bone Growth Therapies and Spinal Implants, Biologics, and Enabling Technologies. Bone Growth Therapies includes noninvasive stimulation devices used in spinal fusion and fracture-healing applications. Spinal Implants, Biologics, and Enabling Technologies includes a broad portfolio of spine fixation and motion-preservation products, biologic solutions, and image-guided surgical technologies used in spine procedures. The Global Limb Reconstruction segment provides products and solutions for limb reconstruction, deformity correction, fracture management, and other orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX. |
| URL | http://www.orthofix.com |
| Investor Relations URL | https://ir.orthofix.com |
| HQ State/Province | Texas |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Small Cap Core |
| Next Earnings Release | Nov. 03, 2026 (est.) |
| Last Earnings Release | Aug. 05, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Orthofix Medical, Inc. develops and markets medical devices and biologic solutions for spine and orthopedic applications. The company operates through two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers two primary product categories: Bone Growth Therapies and Spinal Implants, Biologics, and Enabling Technologies. Bone Growth Therapies includes noninvasive stimulation devices used in spinal fusion and fracture-healing applications. Spinal Implants, Biologics, and Enabling Technologies includes a broad portfolio of spine fixation and motion-preservation products, biologic solutions, and image-guided surgical technologies used in spine procedures. The Global Limb Reconstruction segment provides products and solutions for limb reconstruction, deformity correction, fracture management, and other orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX. |
| URL | http://www.orthofix.com |
| Investor Relations URL | https://ir.orthofix.com |
| HQ State/Province | Texas |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Small Cap Core |
| Next Earnings Release | Nov. 03, 2026 (est.) |
| Last Earnings Release | Aug. 05, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |